TORONTO—Use of an oral phosphodiesterase type-5 inhibitor (PDE5i) significantly reduces urinary incontinence after radical prostatectomy (RP), according to data presented at the joint annual meeting of the International Continence Society and the International Urogynecological Association.

Twenty years ago, a man I revered calmly shared the news that he had just been diagnosed with metastatic prostate cancer. Frank A. Oski, MD, was chair of pediatrics at Johns Hopkins, a beloved, iconic, and iconoclastic figure to thousands of students, faculty, and practicing clinicians throughout the realm of children's health care, a brilliant mind who loved nothing better than tweaking the pretensions of the medically effete.

Active surveillance may be a suitable option for many men with low-risk prostate cancer (PCa), Swedish researchers concluded.

SAN FRANCISCO—Initiating statin therapy after radical prostatectomy (RP) may decrease the risk of biochemical recurrence of prostate cancer, new data suggest.

Deaths from prostate cancer (PCa) fell by almost half after 14 years of biennial screening, according to data from a Swedish study.

Acupuncture may be an effective treatment for hot flashes in men receiving androgen deprivation therapy (ADT) for prostate cancer (PCa), according to findings published online in Urology.

CHICAGO—Tasquinimod, a novel biologic agent, may significantly slow the rate of disease progression and improve progression-free survival in patients with metastatic castrate-resistant prostate cancer (CRCP), according to a new study presented at the American Society of Clinical Oncology annual meeting.

Aspirin use is associated with a significantly decreased risk of prostate cancer, with the greatest reduction in risk found with daily use of low doses of the drug, according to researchers.

Vaccine for advanced castration-resistant prostate cancer prolongs life by a median of four months, but at an extremely high cost.

Most men with PSA levels of 4 ng/mL or below and who have been diagnosed with prostate cancer have low-risk disease yet undergo aggressive local treatment, a study found.